Expression of concern
Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 2: Current management
Paper Information
Record ID:
35124
Author(s):
Journal:
Publication Date:
December 01, 2012
Retraction Date:
January 24, 2022
(3.8 years years ago)
Subjects:
Broad Categories:
Medicine
Medicine
Institutions:
- Department of Medicine 1, Agaplesion Markus Hospital, Wilhelm-Epstein-Str. 4, D-60431 Frankfurt/Main, Germany
- Division of Gastroenterology, Department of Medicine, MtSinai Hospital and University Health Network
- University of Toronto, 600 University Avenue, Toronto, ON, Canada
- M5G 1X5 and University of Leuven, Belgium
Countries:
Article Type:
Publisher:
Oxford Academic
Open Access:
Yes
PubMed ID:
Retraction PubMed ID:
Expression of concern Details
Retraction Reasons:
Nature of Retraction:
Expression of concern
Retraction Notice:
10.1093/ecco-jcc/jjab227Additional Notes:
See also: https://doi.org/10.1093/ecco-jcc/jjab225 Journal was previously published by Elsevier until 2015.
Citations (1561)
1561
Total Citations239
Post-Retraction(15.3%)
1316
Pre-Retraction1
Same DayPost-Retraction Citation Analysis
9
Within 30 days
111
Within 1 year
61
After 2+ years
1218
Days since retraction (latest)
Changes in the clinical course and prognosis of ulcerative colitis in Chinese populations: a retrospective cohort study
Xinyu Liu, Qingfan Yang, Na Diao et al. (7 authors)
Intestinal Research
Open Access
Published: May 2024
1 citation
1 citation
834 days after retraction
Lycium barbarum polysaccharide remodels colon inflammatory microenvironment and improves gut health
Rong Li, Ping Yang, Bowen Liu et al. (10 authors)
Heliyon
Open Access
Published: May 2024
11 citations
11 citations
828 days after retraction
A New Risk Prediction Model for Detecting Endoscopic Activity of Ulcerative Colitis
Guoyu Guan, Sangdan Zhuoga, Songbai Zheng et al. (8 authors)
Gut and Liver
Open Access
Published: Apr 2024
813 days after retraction
Efficacy and Safety of Etrasimod in Patients with Moderately to Severely Active Isolated Proctitis: Results From the Phase 3 ELEVATE UC Clinical Programme
Laurent Peyrin–Biroulet, Marla C. Dubinsky, Bruce E. Sands et al. (19 authors)
Journal of Crohn s and Colitis
Open Access
Published: Apr 2024
19 citations
19 citations
810 days after retraction
Faecal Microbiota Transplantation Engraftment After Budesonide or Placebo in Patients With Active Ulcerative Colitis Using Pre-selected Donors: A Randomized Pilot Study
Emilie van Lingen, Sam Nooij, Elisabeth M. Terveer et al. (17 authors)
Journal of Crohn s and Colitis
Open Access
Published: Apr 2024
8 citations
8 citations
800 days after retraction
A Review on Nanosystem-Based Delivery of Tofacitinib for Enhanced Treatment of Autoimmune Diseases and Inflammation
Thi‐Thao‐Linh Nguyen, Van‐An Duong
BioNanoScience
Published: Apr 2024
4 citations
4 citations
798 days after retraction
Post-hospitalization Short Versus Long Steroid Taper Strategies in Patients With Acute Severe Ulcerative Colitis: A Comparison of Clinical Outcomes
Mohammad Alomari, Pravallika Chadalavada, Sadaf Afraz et al. (11 authors)
Crohn s & Colitis 360
Open Access
Published: Apr 2024
3 citations
3 citations
798 days after retraction
Etrolizumab as an induction and maintenance therapy for ulcerative colitis: A systematic review and meta‐analysis of randomized controlled trials
Othman Saleh, Mohamed Abuelazm, Islam Mohamed et al. (8 authors)
JGH Open
Open Access
Published: Apr 2024
1 citation
1 citation
798 days after retraction
Melanocortin 3,5 receptors immunohistochemical expression in colonic mucosa of inflammatory bowel disease patients: A matter of disease activity?
Antonietta Gerarda Gravina, Iacopo Panarese, Maria Consiglia Trotta et al. (10 authors)
World Journal of Gastroenterology
Open Access
Published: Mar 2024
18 citations
18 citations
771 days after retraction
The effect of anti-TNF drugs on the intestinal microbiota in patients with spondyloarthritis, rheumatoid arthritis, and inflammatory bowel diseases
Francesco Ciccia, Nikolas Dussias, Saviana Gandolfo et al. (5 authors)
Rheumatology and Immunology Research
Open Access
Published: Mar 2024
3 citations
3 citations
767 days after retraction
Short noncoding RNAs as predictive biomarkers for the development from inflammatory bowel disease unclassified to Crohn’s disease or ulcerative colitis
Jaslin James, Lene Riis, Rolf Søkilde et al. (7 authors)
PLoS ONE
Open Access
Published: Feb 2024
1 citation
1 citation
763 days after retraction
An assessment system for clinical and biological interpretability in ulcerative colitis
Shiqian Zhang, Ge Zhang, Wenxiu Wang et al. (13 authors)
Aging
Open Access
Published: Feb 2024
5 citations
5 citations
753 days after retraction
Current Approaches for Monitoring of Patients with Inflammatory Bowel Diseases: A Narrative Review
Alessandro Vitello, Marcello Maida, Endrit Shahini et al. (9 authors)
Journal of Clinical Medicine
Open Access
Published: Feb 2024
7 citations
7 citations
746 days after retraction
Effect of huankuile on colon injury in rats with ulcerative colitis by reducing TNF-α and MMP9
Xilinguli Wushouer, Kasimujiang Aximujiang, Nafeisha Kadeer et al. (6 authors)
European journal of medical research
Open Access
Published: Feb 2024
6 citations
6 citations
743 days after retraction
Longitudinal Measurements of Blood Biomarkers in Patients with Crohn’s Disease or Ulcerative Colitis Treated with Infliximab: Only the Latest Values in the Induction Period Predict Treatment Failure
Kim Oren Gradel, Bente Mertz Nørgård, Sonia Friedman et al. (5 authors)
Journal of Clinical Medicine
Open Access
Published: Feb 2024
743 days after retraction
H<sub>2</sub>S‐Releasing Versatile Montmorillonite Nanoformulation Trilogically Renovates the Gut Microenvironment for Inflammatory Bowel Disease Modulation
Ting Jin, Hongyang Lu, Qiang Zhou et al. (10 authors)
Advanced Science
Open Access
Published: Feb 2024
46 citations
46 citations
739 days after retraction
Role of Intestinal Fatty Acid Binding Protein in Treated Inflammatory Bowel Diseases Patients
Reda El-Badawy, Hatem Samir Alegaily, Kamal Abdelrahman Mohamed El Atrebi et al. (6 authors)
Benha Medical Journal
Open Access
Published: Jan 2024
730 days after retraction
Sarcopenia is common in ulcerative colitis and correlates with disease activity
Pardhu B. Neelam, Rimesh Pal, Pankaj Gupta et al. (11 authors)
Intestinal Research
Open Access
Published: Jan 2024
7 citations
7 citations
728 days after retraction
Efficacy and safety of tacrolimus in older adults with ulcerative colitis: a retrospective study
Ayumi Ito, Syun Murasugi, Teppei Omori et al. (5 authors)
BMC Gastroenterology
Open Access
Published: Jan 2024
1 citation
1 citation
714 days after retraction
Prospective study of an adalimumab combined with partial enteral nutrition in the induction period of Crohn’s disease
Sisi Zhou, Zeyu Huang, Wenjing Hou et al. (5 authors)
Inflammation Research
Open Access
Published: Jan 2024
8 citations
8 citations
708 days after retraction
Biomarkers in inflammatory bowel disease: a practical guide
Jennifer Clough, Michael Colwill, Andrew Poullis et al. (6 authors)
Therapeutic Advances in Gastroenterology
Open Access
Published: Jan 2024
14 citations
14 citations
707 days after retraction
The prevalence and impact of psychiatric comorbidities on hospitalized inflammatory bowel disease patients in the United States: insights from the National Inpatient Sample from 2009-2018
Marcella Pimpinelli
Annals of Gastroenterology
Open Access
Published: Jan 2024
1 citation
1 citation
707 days after retraction
Long-term outcomes of cyclosporin induction and ustekinumab maintenance combination therapy in patients with steroid-refractory acute severe ulcerative colitis
Francesco Vitali, Timo Räth, Entcho Klenske et al. (11 authors)
Therapeutic Advances in Gastroenterology
Open Access
Published: Dec 2023
2 citations
2 citations
705 days after retraction
Celecoxib alleviates the DSS-induced ulcerative colitis in mice by enhancing intestinal barrier function, inhibiting ferroptosis and suppressing apoptosis
Yaxian Li, Mengdi Ma, Xiaodong Wang et al. (10 authors)
Immunopharmacology and Immunotoxicology
Published: Dec 2023
7 citations
7 citations
704 days after retraction
Comparing Myelosuppression Frequency in Indian Inflammatory Bowel Disease Patients: A Randomized Trial of Full Dose Versus Gradual Escalation of Thiopurines
Alok Singh, Sanjeev Sachdeva, Siddharth Srivastava et al. (8 authors)
Cureus
Open Access
Published: Dec 2023
1 citation
1 citation
697 days after retraction
Clinical Implications of Dietary Probiotic Supplement (Associated with L-Glutamine and Biotin) in Ulcerative Colitis Patients’ Body Composition and Quality of Life
Flavia Maria Pavel, Simona Bungău, Delia Mirela Ţiț et al. (10 authors)
Nutrients
Open Access
Published: Dec 2023
2 citations
2 citations
683 days after retraction
Personalized Treatment for Crohn’s Disease: Current Approaches and Future Directions
Joseph Clinton, Raymond K. Cross
Clinical and Experimental Gastroenterology
Open Access
Published: Dec 2023
11 citations
11 citations
676 days after retraction
Real-World Experience of Adalimumab Biosimilar (ABP 501) Use in Patients with Inflammatory Bowel Disease in Europe
Ran Jin, Chidozie Nduka, Delphine Courmier et al. (8 authors)
Advances in Therapy
Open Access
Published: Nov 2023
9 citations
9 citations
659 days after retraction
Gut microbiota in pathophysiology, diagnosis, and therapeutics of inflammatory bowel disease
Himani Pandey, Dheeraj Jain, Daryl W. T. Tang et al. (5 authors)
Intestinal Research
Open Access
Published: Nov 2023
29 citations
29 citations
653 days after retraction
Treatment of Patients with Mild to Moderate Ulcerative Colitis: A Middle East Expert Consensus
Sameer Al Awadhi, Mohamed Alboraie, Emad Aldin M. Albaba et al. (16 authors)
Journal of Clinical Medicine
Open Access
Published: Nov 2023
5 citations
5 citations
649 days after retraction
Integrated Network Pharmacology, Molecular Docking and Animal Experiment to Explore the Efficacy and Potential Mechanism of Baiyu Decoction Against Ulcerative Colitis by Enema
Yuan Cui, Jingyi Hu, Yanan Li et al. (11 authors)
Drug Design Development and Therapy
Open Access
Published: Nov 2023
8 citations
8 citations
646 days after retraction
Identifying Macrophage-Related Genes in Ulcerative Colitis Using Weighted Coexpression Network Analysis and Machine Learning
Shaocheng Hong, Hongqian Wang, Shixin Chan et al. (7 authors)
Mediators of Inflammation
Open Access
Published: Oct 2023
639 days after retraction
Repairing the intestinal mucosal barrier of traditional Chinese medicine for ulcerative colitis: a review
Yichen Zong, Jie Meng, Tangyou Mao et al. (6 authors)
Frontiers in Pharmacology
Open Access
Published: Oct 2023
20 citations
20 citations
638 days after retraction
Ulcerative Colitis and Nursing
İlknur Yücel
Health and Technology Journal (HTechJ)
Open Access
Published: Oct 2023
630 days after retraction
Crohn’s Disease: Basic Characteristics of the Disease, Diagnostic Methods, the Role of Biomarkers, and Analysis of Metalloproteinases: A Review
Grzegorz Pasternak, Grzegorz Chrzanowski, David Aebisher et al. (10 authors)
Life
Open Access
Published: Oct 2023
12 citations
12 citations
629 days after retraction
“Prevalence, Predictors, and Impact of Hepatic Steatosis in Patients With Ulcerative Colitis: A Prospective Observational Cohort Study”
Arti Gupta, Sudheer K. Vuyyuru, Bhaskar Kante et al. (14 authors)
Journal of Clinical and Experimental Hepatology
Open Access
Published: Oct 2023
3 citations
3 citations
626 days after retraction
Serial Fecal Microbiota Infusions via Colonoscopy for Active Ulcerative Colitis: A Feasibility, Safety, and Translational Monocentric Italian Study
Loris Riccardo Lopetuso, Lucrezia Laterza, Valentina Petito et al. (19 authors)
Microorganisms
Open Access
Published: Oct 2023
5 citations
5 citations
625 days after retraction
Safety and efficacy of multimatrix mesalamine in paediatric patients with mild-to-moderate ulcerative colitis: a phase 3, randomised, double-blind study
Nicholas M. Croft, Bartosz Korczowski, Jarosław Kierkuś et al. (5 authors)
EClinicalMedicine
Open Access
Published: Oct 2023
3 citations
3 citations
620 days after retraction
Development and multiple visualization methods for the therapeutic effects prediction model of five-flavor Sophora Flavescens enteric-coated capsules in the treatment of active ulcerative colitis: A study on model development and result visualization
Zhijun Bu, Zhi-Rui Huang, Yunru Chen et al. (11 authors)
European Journal of Integrative Medicine
Published: Sep 2023
5 citations
5 citations
586 days after retraction
Danggui Buxue Tang Alleviates Antibiotic-Induced Intestinal Structural Disorders by Affecting Intestinal Bacterial Composition and Thus Bile Acid Metabolism
Dan Chen, Defu Tie, Zhaohui Fan et al. (9 authors)
Pharmaceutical Chemistry Journal
Published: Sep 2023
585 days after retraction
Epidemiology and Demographic Profile of Inflammatory Bowel Disease in Nepal
Mukesh Kumar Ranjan, Rahul Pathak
Journal of Institute of Medicine Nepal
Open Access
Published: Aug 2023
584 days after retraction
Inflammatory Bowel Disease: Pathophysiology, Treatment, and Disease Modeling
Jiryeon Jang, Sehoon Jeong
BioChip Journal
Published: Aug 2023
13 citations
13 citations
582 days after retraction
Statin use and risk of colorectal cancer in patients with inflammatory bowel disease
Jiangwei Sun, Jonas Halfvarson, David Bergman et al. (9 authors)
EClinicalMedicine
Open Access
Published: Aug 2023
17 citations
17 citations
577 days after retraction
Molecular Hybridization as a Strategy for Developing Artemisinin-Derived Anticancer Candidates
Elena Marchesi, Daniela Perrone, Maria Luisa Navacchia
Pharmaceutics
Open Access
Published: Aug 2023
13 citations
13 citations
576 days after retraction
Treatment strategy changes for inflammatory bowel diseases in biologic era: results from a multicenter cohort in Japan, Far East 1000
Takashi Taida, Yuki Ohta, Jun Kato et al. (41 authors)
Scientific Reports
Open Access
Published: Aug 2023
2 citations
2 citations
574 days after retraction
Inflammatory Bowel Disease and Colorectal Cancer: Epidemiology, Etiology, Surveillance, and Management
Yoshihiro Sato, Shingo Tsujinaka, Tomoya Miura et al. (6 authors)
Cancers
Open Access
Published: Aug 2023
48 citations
48 citations
570 days after retraction
Systematic review with meta‐analysis: Medical therapies for treatment of ulcerative proctitis
Achuthan Aruljothy, Siddharth Singh, Neeraj Narula et al. (13 authors)
Alimentary Pharmacology & Therapeutics
Open Access
Published: Aug 2023
6 citations
6 citations
570 days after retraction
Oral manifestations in Inflammatory Bowel Diseases
Christopher Xiu Wen Tan
Unknown Journal
Open Access
Published: Aug 2023
568 days after retraction
Long‐term safety and effectiveness of azathioprine in the management of inflammatory bowel disease: A real‐world experience
Rohan V Yewale, Banumathi Ramakrishna, Babu Vinish Doraisamy et al. (9 authors)
JGH Open
Open Access
Published: Aug 2023
13 citations
13 citations
563 days after retraction
Tissue Metalloproteinases as Crohn Disease Recurrence Markers
Grzegorz Pasternak, Grzegorz Chrzanowski, David Aebisher et al. (7 authors)
Unknown Journal
Open Access
Published: Aug 2023
2 citations
2 citations
561 days after retraction
Quick Stats
Total Citations:
1561
Years Since Retraction:
3.8 years
Open Access:
Yes
Last Checked:
Jul 24, 2025